Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
Patents for C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom (107,979)
12/2010
12/22/2010CN101925597A Solid forms of 1-ethyl-3-(5-(5-fluoropyridin-3-yl)-7-(pyrimidin-2-yl)-1h-benzo[d]imidazol-2-yl)urea
12/22/2010CN101925596A Beta-amino acid derivatives for treatment of diabetes
12/22/2010CN101925595A Phthalazinone derivatives
12/22/2010CN101925584A Pyrimidine derivatives for treatment of asthma, COPD, allergic rhinitis, allergic conjunctivitis, atopic dermatitis, cancer, hepatitis b, hepatitis c, HIV, HPV, bacterial infections and dermatosis
12/22/2010CN101921279A Spirocyclic heterocyclic derivatives and methods of their use
12/22/2010CN101921267A Beta -lactamyl vasopressin Vla antagonists
12/22/2010CN101921262A Compound used as electrochromic material as well as preparation method and application thereof
12/22/2010CN101921261A Separation and recovery process after imidacloprid synthesis
12/22/2010CN101921260A Method for preparing imatinib
12/22/2010CN101921238A Preparation of substituted nitrogen-containing benzoheterocycle derivatives and pharmacological application thereof
12/22/2010CN101921236A 2, 4- di (phenylamino) pyrimidines useful in the treatment of neoplastic diseases, inflammatory and immune system disorders
12/22/2010CN101921224A 1-(3-aminopropyl) piperazine-4-aminoamide compound as well as preparation method and application thereof
12/22/2010CN101497584B Isoquinoline-3-formyl amino acid formyl amino acid benzyl ester, as well as preparation and use thereof
12/22/2010CN101208330B Method of preparing esomeprazole and salts thereof
12/22/2010CN101128436B Glycine derivative and use thereof
12/22/2010CN101056864B Method for preparing pyrimidine compound
12/21/2010US7855298 (1S,5R)-1-[2-fluoro-4-(trifluoromethyl)phenyl]-3-{3-[(4-methyl-5-phenyl-4H-1,2,4-triazol-3-yl)oxy]propyl}-3-azabicyclo[3.1.0]hexane; or(1S,5R)-3-{3-[(4-methyl-5-phenyl-4H-1,2,4-triazol-3-yl)oxy]propyl}-1-[4-(trifluoromethyl)phenyl]-3-azabicyclo[3.1.0]hexane; schizophrenia
12/21/2010US7855297 Amide derivatives and medicinal use thereof
12/21/2010US7855294 (6R,8S)-6-(spiro[isobenzofuran-1-(3H), 4'-piperidin]-1'-ylmethyl)-5,6,7,8-tetrahydroquinolin-8-ol), exhibiting an antagonism to binding of nociceptin to opioid receptor-like-1 receptors, useful as medicines for diseases associated with pain and appetite control or memory and learning
12/21/2010US7855293 Fluorescent dyes such as 2-(4-acetanilino-1,3-butadieneyl)-3-spiro-1'-cyclohexan-1-(4-sulfobutyl)-3H -indolium hydroxide metal salts which couple biological materials without loss of fluorescence due to self-quenching
12/21/2010US7855290 Pyridine derivatives and pyrimidine derivatives (3)
12/21/2010US7855222 indazole derivatives such as 5-[4-(1-amino-1-methylethyl)phenyl]-1H-indazole, used for the treatment of vision defects
12/21/2010US7855219 2-Amino-4-(1,3-benzodioxol-5-yl)-6-benzyloxy-3,5-pyridinedicarbonitrile, acting as adenosine-receptor-selective ligands, for the prophylaxis and/or treatment of cardiovascular disorders
12/21/2010US7855218 (5R)-5-(4-{[(2-fluorophenyl)methyl]oxy}phenyl)-L-prolinamide; depression or a mood disorder ; modulation of use-dependent voltage-gated sodium channels
12/21/2010US7855217 Polymorphic forms of 3-(4-amino-1-oxo-1,3 dihydro-isoindol-2-yl)-piperidine-2,6-dione
12/21/2010US7855215 such as 6-(6-Amino-pyrimidin-4-yloxy)-3,4-dihydro-2H-quinoline-1-carboxylic acid (3-trifluoromethyl-phenyl)-amide, used for the treatment of leukemia
12/21/2010US7855212 Pyridinyl acetonitriles
12/21/2010US7855211 such as [5-(4-Ethyl-piperazin-1-ylmethyl)-pyridin-2-yl]-[5-fluoro-4-(7-fluoro-3-isopropyl-2-methyl-3H-benzoimidazol-5-yl)-pyrimidin-2-yl]-amine, useful in the treatment of cell proliferative diseases
12/21/2010US7855210 Hydroxyiminopiperazine compounds, used as vanilloid receptor antagonists; analgesics
12/21/2010US7855207 such as 6-[(1R)-1-(2,3-dihydro-1,4-benzodioxin-6-yl)-3-piperidin-1-ylpropyl]-3-ethyl-1H-quinolin-2-one, used for treating cancer and/or preventing cellular, tissue and/or organ damage resulting from cell damage or death due to, for example, necrosis or apoptosis
12/21/2010US7855203 Indazolyl-substituted pyrroline compounds as kinase inhibitors
12/21/2010US7855198 Benzamide derivative or salt thereof
12/21/2010US7855194 Pyrimidine, quinazoline, pteridine and triazine derivatives
12/21/2010CA2659682C Prolyl hydroxylase inhibitors and methods of use
12/21/2010CA2577937C Pyrazole-substituted aminoheteroaryl compounds as protein kinase inhibitors
12/21/2010CA2569654C Benzimidazolone carboxylic acid derivatives
12/21/2010CA2494024C Prodrugs of 1-methyl-2-(4-amidinophenylaminomethyl)-benzimidazol-5-yl-carboxylic acid-(n-2-pyridyl-n-2-hydroxycarbonylethyl)-amide,the preparation thereof and their use as pharmaceutical compositions
12/21/2010CA2492718C Prodrugs of proton pump inhibitors
12/21/2010CA2457575C 3-phenoxy-4-pyridazinol derivatives and herbicidal composition containing the same
12/21/2010CA2432137C Crystal forms of 6-[(4-chloro-phenyl)-hydroxy-(3-methyl-3h-imidazol-4-yl)-methyl]-4-(3-ethynyl-phenyl)-1-methyl-1h-quinolin-2-one, 2,3-dihydroxybutanedioate salts and method of production
12/21/2010CA2423351C Novel arylalkane-sulfonamides
12/21/2010CA2406255C Hydroxylamine esters as polymerization initiators
12/21/2010CA2404594C Agent for prophylaxis and treatment of renal disease
12/21/2010CA2401778C Benzamides and related inhibitors of factor xa
12/21/2010CA2397981C Azacyclic compounds for use in the treatment of serotonin related diseases
12/16/2010WO2010144647A1 Nicotinamide compounds useful as kinase modulators
12/16/2010WO2010144293A1 Synthesis of telcagepant and intermediates thereof
12/16/2010WO2010143733A1 Novel fused cyclic compound and use thereof
12/16/2010WO2010143664A1 Tetracyclic compound
12/16/2010WO2010143170A2 Compounds useful for treating premature aging and in particular progeria
12/16/2010WO2010143169A2 Compounds useful for treating aids
12/16/2010WO2010143168A2 Compounds useful for treating cancer
12/16/2010WO2010142985A1 Substituted n-[1-cyano-2-(phenyl)ethyl]piperidin-2-ylcarboxmide compounds 761
12/16/2010WO2010142934A1 Indole derivatives as ligands of crth2 receptors
12/16/2010WO2010142752A1 Janus kinase inhibitor compounds and methods
12/16/2010WO2010142656A1 Heterocyclic antiviral compounds
12/16/2010WO2010142426A1 Hedgehog pathway antagonists and therapeutic applications thereof
12/16/2010WO2010142402A1 Substituted benzimidazoles, benzothiazoles and benzoxazoles
12/16/2010WO2010129467A8 Compounds and methods for inhibition of renin, and indications therefor
12/16/2010WO2010052569A3 Triazine, pyrimidine and pyridine analogs and their use as therapeutic agents and diagnostic probes
12/16/2010US20100317864 Preparation Method of Phenylcarboxamides
12/16/2010US20100317857 Process for preparing anhydrous aripirazole type i
12/16/2010US20100317853 Novel imatinib camsylate and method for preparing thereof
12/16/2010US20100317851 Luminophores
12/16/2010US20100317842 Development of Molecular Imaging Probes for Carbonic Anhydrase-IX Using Click Chemistry
12/16/2010US20100317712 Estrogen Agonists/Antagonists For Preventing Breast Cancer
12/16/2010US20100317698 Polysubstituted Pyridinylaminoalkylene- and Pyridinyloxyalkylene-Cyclopropanamine Compounds, a Process for Their Preparation and Pharmaceutical Compositions Containing Them
12/16/2010US20100317680 Pyrimidine inhibitors of kinases
12/16/2010US20100317679 Substituted aryl-fused spirocyclic amines
12/16/2010US20100317678 Hydroxamates as inhibitors of histone deacetylase
12/16/2010US20100317674 Metabotropic Glutamate-Receptor-Potentiating Isoindolones
12/16/2010US20100317670 Therapeutic agents useful for treating pain
12/16/2010US20100317669 Novel substituted piperidyl-propane-thiols
12/16/2010US20100317665 Anti-Inflammatory And Protein Kinase Inhibitor Compositions And Related Methods For Downregulation Of Detrimental Cellular Responses And Inhibition Of Cell Death
12/16/2010US20100317663 Anilinopyridines as inhibitors of fak
12/16/2010US20100317660 Mediators of hedgehog signaling pathways, compositions and uses related thereto
12/16/2010US20100317652 Compounds Useful In Therapy
12/16/2010US20100317647 Novel cyclopentane derivatives
12/16/2010US20100317644 Substituted Sulfonamide Compounds
12/16/2010US20100317643 Janus kinase inhibitor compounds and methods
12/16/2010US20100317641 Thiazoles and pyrazoles useful as kinase inhibitors
12/16/2010US20100317634 Piperidyl-propane-thiol ccr3 modulators
12/16/2010US20100317630 Novel heterocyclic compounds as mglu5 antagonists
12/16/2010US20100317618 1-benzyl-3-hydroxymethylindazole derivatives and use thereof in the treatment of diseases based on the expression of mcp-1 and cx3cr1
12/16/2010US20100317607 Use of compounds for preparing anti-tuberculosis agents
12/16/2010US20100317568 Anti-Viral Compounds
12/16/2010US20100317031 Ultra-sensitive chemiluminescent substrates for enzymes and their conjugates
12/16/2010US20100316607 Hepatitis c virus inhibitors
12/16/2010US20100316605 Inhibitors of phosphatidylinositol 3-kinase
12/16/2010US20100316573 Organic Compounds
12/16/2010US20100314611 Electrode covering material, electrode structure and semiconductor device
12/16/2010CA2847910A1 Anti-viral compounds
12/16/2010CA2802334A1 Compositions and methods for imaging tissues, organs and tumors
12/16/2010CA2765114A1 Hedgehog pathway antagonists and therapeutic applications thereof
12/16/2010CA2765047A1 Pyridyl-triazine inhibitors of hedgehog signaling
12/16/2010CA2765030A1 Triazine derivatives and their therapeutical applications
12/16/2010CA2764980A1 Styryl-triazine derivatives and their therapeutical applications
12/16/2010CA2764823A1 Triazine derivatives and their therapeutical applications
12/16/2010CA2764818A1 Triazine derivatives and their therapeutical applications
12/16/2010CA2764728A1 Janus kinase inhibitor compounds and methods
1 ... 221 222 223 224 225 226 227 228 229 230 231 232 233 234 235 236 237 238 239 240 241 ... 1080